Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome
Status:
Not yet recruiting
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
The primary goal of the study is to assess the efficacy and safety of RPH-104 in subjects
with Schnitzler Syndrome using Schnitzler Disease Activity Score (SDAS), which includes the
Physician's Global Assessment (PGA) and the local laboratory C-reactive protein (CRP) result